We are now globally represented by our subsidiaries or sales partners in over 15 Countries: Uzbekistan, Nigeria, Kenya, Uganda, Sri Lanka, Nepal, Myanmar, Yemen, Honduras, Venezuela, Tanzania, Ethiopia, Philippines, Malaysia & Ivory coast.

More than 50 products have been registered in these countries.

With our research, development and marketing co-operations, we are determined to continue consolidating our position in the global pharmaceutical market. Our innovative, internationally oriented marketing strategy forms a sound basis for these efforts

In October 2018, Medyra Pharmaceuticals entered into a joint venture with SILUJIN Private Co. Ltd, to manufacture Oncology drugs in Uzbekistan. Medyra Pharmaceuticals is first Indian company to manufacture Oncology drugs in Uzbekistan.